Impact of the SARS-CoV-2 on the journey of high-risk colon cancer patients within the scope of the Unified Health System in Brazil
Abstract Background Colon cancer is an important cause of mortality related to cancer. During the COVID-19 pandemic, an important reallotment of assistance resources was necessary to tackle the crisis, directly impacting medical practice all over the globe. Objective To assess the impact of the Sars...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2023-10-01
|
| Series: | BMC Health Services Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12913-023-10083-9 |
| _version_ | 1797453430354083840 |
|---|---|
| author | Raquel Pucci de Oliveira Pedro Henrique Rezende de Moraes Ana Paula Drummond-Lage |
| author_facet | Raquel Pucci de Oliveira Pedro Henrique Rezende de Moraes Ana Paula Drummond-Lage |
| author_sort | Raquel Pucci de Oliveira |
| collection | DOAJ |
| description | Abstract Background Colon cancer is an important cause of mortality related to cancer. During the COVID-19 pandemic, an important reallotment of assistance resources was necessary to tackle the crisis, directly impacting medical practice all over the globe. Objective To assess the impact of the Sars-Cov-2 pandemic on the time between diagnosis and the beginning of systemic treatment in patients diagnosed with high-risk colon neoplasia. Methods This is a retrospective study based on the analysis of medical records of patients diagnosed with colon neoplasia who required systemic treatment and were treated between March 2019 and March 2022, in a reference Oncology unit of the Brazilian Unified Health System. The study’s population was divided into two groups: (I) Pre-COVID-19: diagnoses made between March 2019 and February 2020, (II) COVID-19: diagnoses made between March 2020 and March 2022. Results The sample consisted of 228 patients, 108 (47.97%) of whom were diagnosed during pre-COVID-19 and 118 (52.21%) diagnosed during the two years-period of COVID-19. Regarding the time between colonoscopy and surgery, the time between surgery and first consultation in clinical oncology, and the time between requesting and beginning of systemic treatment, a statistically significant reduction was observed during the COVID-19 period. Conclusion A decrease in time between diagnosis and systemic treatment of patients with colorectal cancer during the COVID-19 pandemic was observed. Yet, even with this improvement, the time to begin treatment remains greater than the recommended by the current guidelines, regardless of the time of diagnosis (before or after the pandemic), which negatively impacts the disease outcome. |
| first_indexed | 2024-03-09T15:22:42Z |
| format | Article |
| id | doaj.art-b5dba4e0e6e74de5a9335b8b3525c4d0 |
| institution | Directory Open Access Journal |
| issn | 1472-6963 |
| language | English |
| last_indexed | 2024-03-09T15:22:42Z |
| publishDate | 2023-10-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Health Services Research |
| spelling | doaj.art-b5dba4e0e6e74de5a9335b8b3525c4d02023-11-26T12:42:39ZengBMCBMC Health Services Research1472-69632023-10-012311910.1186/s12913-023-10083-9Impact of the SARS-CoV-2 on the journey of high-risk colon cancer patients within the scope of the Unified Health System in BrazilRaquel Pucci de Oliveira0Pedro Henrique Rezende de Moraes1Ana Paula Drummond-Lage2Faculdade Ciências Médicas de Minas GeraisFaculdade Ciências Médicas de Minas GeraisFaculdade Ciências Médicas de Minas GeraisAbstract Background Colon cancer is an important cause of mortality related to cancer. During the COVID-19 pandemic, an important reallotment of assistance resources was necessary to tackle the crisis, directly impacting medical practice all over the globe. Objective To assess the impact of the Sars-Cov-2 pandemic on the time between diagnosis and the beginning of systemic treatment in patients diagnosed with high-risk colon neoplasia. Methods This is a retrospective study based on the analysis of medical records of patients diagnosed with colon neoplasia who required systemic treatment and were treated between March 2019 and March 2022, in a reference Oncology unit of the Brazilian Unified Health System. The study’s population was divided into two groups: (I) Pre-COVID-19: diagnoses made between March 2019 and February 2020, (II) COVID-19: diagnoses made between March 2020 and March 2022. Results The sample consisted of 228 patients, 108 (47.97%) of whom were diagnosed during pre-COVID-19 and 118 (52.21%) diagnosed during the two years-period of COVID-19. Regarding the time between colonoscopy and surgery, the time between surgery and first consultation in clinical oncology, and the time between requesting and beginning of systemic treatment, a statistically significant reduction was observed during the COVID-19 period. Conclusion A decrease in time between diagnosis and systemic treatment of patients with colorectal cancer during the COVID-19 pandemic was observed. Yet, even with this improvement, the time to begin treatment remains greater than the recommended by the current guidelines, regardless of the time of diagnosis (before or after the pandemic), which negatively impacts the disease outcome.https://doi.org/10.1186/s12913-023-10083-9Chemotherapy (adjuvantMetastatic)colon cancerCOVID-19DelayPandemic |
| spellingShingle | Raquel Pucci de Oliveira Pedro Henrique Rezende de Moraes Ana Paula Drummond-Lage Impact of the SARS-CoV-2 on the journey of high-risk colon cancer patients within the scope of the Unified Health System in Brazil BMC Health Services Research Chemotherapy (adjuvant Metastatic) colon cancer COVID-19 Delay Pandemic |
| title | Impact of the SARS-CoV-2 on the journey of high-risk colon cancer patients within the scope of the Unified Health System in Brazil |
| title_full | Impact of the SARS-CoV-2 on the journey of high-risk colon cancer patients within the scope of the Unified Health System in Brazil |
| title_fullStr | Impact of the SARS-CoV-2 on the journey of high-risk colon cancer patients within the scope of the Unified Health System in Brazil |
| title_full_unstemmed | Impact of the SARS-CoV-2 on the journey of high-risk colon cancer patients within the scope of the Unified Health System in Brazil |
| title_short | Impact of the SARS-CoV-2 on the journey of high-risk colon cancer patients within the scope of the Unified Health System in Brazil |
| title_sort | impact of the sars cov 2 on the journey of high risk colon cancer patients within the scope of the unified health system in brazil |
| topic | Chemotherapy (adjuvant Metastatic) colon cancer COVID-19 Delay Pandemic |
| url | https://doi.org/10.1186/s12913-023-10083-9 |
| work_keys_str_mv | AT raquelpuccideoliveira impactofthesarscov2onthejourneyofhighriskcoloncancerpatientswithinthescopeoftheunifiedhealthsysteminbrazil AT pedrohenriquerezendedemoraes impactofthesarscov2onthejourneyofhighriskcoloncancerpatientswithinthescopeoftheunifiedhealthsysteminbrazil AT anapauladrummondlage impactofthesarscov2onthejourneyofhighriskcoloncancerpatientswithinthescopeoftheunifiedhealthsysteminbrazil |